Naturhouse Health, S.A. (NTH.MC)
EUR 1.73
(-1.7%)
EUR 1.73
(-1.7%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -19.33 Million EUR | -118.69% |
| 2022 | -8.84 Million EUR | 64.67% |
| 2021 | -25.02 Million EUR | -39.66% |
| 2020 | -17.91 Million EUR | -584.6% |
| 2019 | -2.61 Million EUR | 68.25% |
| 2018 | -8.24 Million EUR | 0.58% |
| 2017 | -8.29 Million EUR | 48.1% |
| 2016 | -15.97 Million EUR | 10.35% |
| 2015 | -17.81 Million EUR | -719.46% |
| 2014 | -2.17 Million EUR | -112.71% |
| 2013 | 17.1 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -24.28 Million EUR | -14.38% |
| 2024 Q2 | -24.28 Million EUR | 13.66% |
| 2023 FY | -19.33 Million EUR | -118.69% |
| 2023 Q2 | -18.73 Million EUR | 0.0% |
| 2023 Q4 | -21.22 Million EUR | 0.0% |
| 2023 Q3 | - EUR | 100.0% |
| 2023 Q1 | - EUR | 100.0% |
| 2022 Q4 | -8.84 Million EUR | 0.0% |
| 2022 Q2 | -17.8 Million EUR | -20.11% |
| 2022 FY | -8.84 Million EUR | 64.67% |
| 2022 Q1 | -14.82 Million EUR | 40.75% |
| 2022 Q3 | - EUR | 100.0% |
| 2021 Q2 | -28.57 Million EUR | -34.74% |
| 2021 FY | -25.02 Million EUR | -39.66% |
| 2021 Q4 | -25.02 Million EUR | 0.0% |
| 2021 Q1 | -21.2 Million EUR | -18.35% |
| 2020 Q3 | -15.22 Million EUR | -64.06% |
| 2020 Q4 | -17.91 Million EUR | -17.65% |
| 2020 Q2 | -9.28 Million EUR | -124.96% |
| 2020 Q1 | -4.12 Million EUR | -57.66% |
| 2020 FY | -17.91 Million EUR | -584.6% |
| 2019 Q2 | -2.48 Million EUR | 46.23% |
| 2019 FY | -2.61 Million EUR | 68.25% |
| 2019 Q3 | 157 Thousand EUR | 106.32% |
| 2019 Q1 | -4.62 Million EUR | 43.91% |
| 2019 Q4 | -2.61 Million EUR | -1766.88% |
| 2018 FY | -8.24 Million EUR | 0.58% |
| 2018 Q3 | -8.33 Million EUR | 46.79% |
| 2018 Q4 | -8.24 Million EUR | 1.14% |
| 2018 Q2 | -15.66 Million EUR | -17.62% |
| 2018 Q1 | -13.32 Million EUR | -60.68% |
| 2017 Q1 | -18.68 Million EUR | -17.0% |
| 2017 FY | -8.29 Million EUR | 48.1% |
| 2017 Q2 | -16.48 Million EUR | 11.8% |
| 2017 Q3 | -8.94 Million EUR | 45.75% |
| 2017 Q4 | -8.29 Million EUR | 7.29% |
| 2016 Q2 | -25.17 Million EUR | -16.55% |
| 2016 Q1 | -21.6 Million EUR | -21.26% |
| 2016 FY | -15.97 Million EUR | 10.35% |
| 2016 Q4 | -15.97 Million EUR | 8.65% |
| 2016 Q3 | -17.48 Million EUR | 30.56% |
| 2015 Q4 | -17.81 Million EUR | -77.21% |
| 2015 Q3 | -10.05 Million EUR | 28.64% |
| 2015 Q2 | -14.08 Million EUR | -1528.67% |
| 2015 Q1 | -865 Thousand EUR | 60.21% |
| 2015 FY | -17.81 Million EUR | -719.46% |
| 2014 FY | -2.17 Million EUR | -112.71% |
| 2014 Q4 | -2.17 Million EUR | 0.0% |
| 2013 FY | 17.1 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Ebro Foods, S.A. | 303.64 Million EUR | 106.367% |
| Deoleo, S.A. | 118.07 Million EUR | 116.374% |